Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]
News [6141]
Articles [120]
Editorials [18]
Conferences [181]
elearning [32]
Multiple myeloma in the elderly
Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA
Multiple myeloma in the elderly ( Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA )
22 Nov 2016
New optimism for advanced breast cancer patients failing antiestrogens: Opening...
Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy
New optimism for advanced breast cancer patients failing antiestrogens: Opening audience survey ( Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy )
15 Nov 2016
Biology and function of CDKs
Dr Ghadeer Shubassi - Institute of Molecular Oncology, Milan, Italy
Biology and function of CDKs ( Dr Ghadeer Shubassi - Institute of Molecular Oncology, Milan, Italy )
15 Nov 2016
Clinical data on breast cancer trials
Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy
Clinical data on breast cancer trials ( Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy )
15 Nov 2016
CDK 4/6 inhibitors: Management of side effects
Dr Alison Jones - The LOC, London, UK
CDK 4/6 inhibitors: Management of side effects ( Dr Alison Jones - The LOC, London, UK )
15 Nov 2016
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )
2 Nov 2016
How can we make the best decisions for health whilst considering cost?
Dr Andrea Manca - University of York, York, UK
How can we make the best decisions for health whilst considering cost? ( Dr Andrea Manca - University of York, York, UK )
1 Nov 2016
Coming of age for CDK 4/6 inhibitors: Welcome and interactive session
Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy
Coming of age for CDK 4/6 inhibitors: Welcome and interactive session ( Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2016
What are CDKs?
Dr Ghadeer Shubassi - FIRC Institute of Molecular Oncology (IFOM), Milan, Italy
What are CDKs? ( Dr Ghadeer Shubassi - FIRC Institute of Molecular Oncology (IFOM), Milan, Italy )
26 Oct 2016
Biomarkers of sensitivity and resistance
Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biomarkers of sensitivity and resistance ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
26 Oct 2016
Editor's ESMO 2016 roundup
Prof Gordon McVie - Editor in Chief, ecancer
Editor's ESMO 2016 roundup ( Prof Gordon McVie - Editor in Chief, ecancer )
24 Oct 2016
Abiraterone in patients with recurrent epithelial ovarian cancer
Dr Susanna Banerjee - The Royal Marsden, London, UK
Abiraterone in patients with recurrent epithelial ovarian cancer ( Dr Susanna Banerjee - The Royal Marsden, London, UK )
24 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation